NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,600
-9.5%
2700.0%0.00%
Q2 2023$2,873
-96.2%
270
-96.3%
0.00%
Q1 2023$76,480
+2186.4%
7,270
+2592.6%
0.00%
Q4 2022$3,345
+11.5%
2700.0%0.00%
Q3 2022$3,0000.0%2700.0%0.00%
Q2 2022$3,000
-81.2%
270
-78.7%
0.00%
Q1 2022$16,000
+6.7%
1,2700.0%0.00%
Q4 2021$15,000
-11.8%
1,2700.0%0.00%
Q3 2021$17,000
+6.2%
1,2700.0%0.00%
Q2 2021$16,000
+14.3%
1,2700.0%0.00%
Q1 2021$14,0000.0%1,2700.0%0.00%
Q4 2020$14,000
+27.3%
1,2700.0%0.00%
Q3 2020$11,000
-15.4%
1,2700.0%0.00%
Q2 2020$13,000
-7.1%
1,270
-7.0%
0.00%
Q1 2020$14,000
-22.2%
1,3650.0%0.00%
Q4 2019$18,000
+63.6%
1,365
+7.5%
0.00%
Q3 2019$11,000
-21.4%
1,2700.0%0.00%
Q2 2019$14,000
-22.2%
1,270
-3.2%
0.00%
Q1 2019$18,000
+500.0%
1,312
+320.5%
0.00%
Q4 2018$3,000
-40.0%
312
+15.6%
0.00%
Q3 2018$5,0000.0%2700.0%0.00%
Q2 2018$5,000
+25.0%
2700.0%0.00%
Q1 2018$4,0000.0%2700.0%0.00%
Q4 2017$4,0000.0%2700.0%0.00%
Q3 2017$4,000
+33.3%
270
+59.8%
0.00%
Q4 2016$3,000
+50.0%
169
+14.2%
0.00%
Q2 2016$2,0000.0%1480.0%0.00%
Q1 2016$2,0001480.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders